Dr. Frank Wathen, MD

Dr. Frank Wathen, MD is a dedicated medical writer specializing in behavioral health, with a robust background in Psychiatry and clinical expertise in psychopharmacology. He earned his Bachelor of Science in Physiological Science from UCLA and his Doctor of Medicine from Texas Tech University Health Sciences Center School of Medicine. After completing a year of direct patient care as a resident, Dr. Wathen transitioned to a career in the biotech and pharmaceutical industries. His experience spans medical writing, where he has authored numerous articles on addiction psychiatry, and clinical trial management, where he has successfully executed and overseen various clinical studies. These roles have honed his ability to translate complex medical data into accessible and impactful content, bridging the gap between scientific research and practical applications to advance patient care standards.

Chronic Use of Benzodiazepines and the Risk of Addiction

October 21, 2024July 15, 2024 by Dr. Frank Wathen, MD

History of Benzodiazepines Benzodiazepines, commonly known as “benzos,” have played a pivotal role in treating anxiety, insomnia, and related conditions since the 1960s. Discovered by Leo Sternbach in 1955, chlordiazepoxide (Librium) became the first benzodiazepine on the market in 1960. Diazepam (Valium), launched in 1963, quickly gained widespread use and became one of the most … Read more

Methamphetamine Addiction: A Growing Crisis and Challenges in Treatment

October 24, 2024July 10, 2024 by Dr. Frank Wathen, MD

Introduction While the opioid epidemic and fentanyl overdoses have dominated the public health discourse, methamphetamine use has been quietly rising. Often overshadowed by opioids, methamphetamine poses significant dangers, particularly in the growing trend of dual methamphetamine and fentanyl use. According to data from the Centers for Disease Control and Prevention’s State Unintentional Drug Overdose Reporting … Read more

© Rehabifyme 2024 | Made with ❤️ by Teckshop 🚀